GVAX Pancreas cancer vaccine: Phase IIb data

Top-line data from the open-label, North American Phase IIb ECLIPSE trial in 303 patients with metastatic pancreatic cancer who failed >=2

Read the full 210 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE